Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension

被引:29
作者
Ivy, DD
Parker, D
Doran, A
Parker, D
Kinsella, JP
Abman, SH
机构
[1] Childrens Hosp, Denver, CO 80218 USA
[2] Univ Colorado, Sch Med, Sect Cardiol, Pediat Heart Lung Ctr, Boulder, CO 80309 USA
[3] Univ Colorado, Sch Med, Sect Pulm, Pediat Heart Lung Ctr, Boulder, CO 80309 USA
[4] Univ Colorado, Sch Med, Sect Neonatol, Pediat Heart Lung Ctr, Boulder, CO 80309 USA
[5] Univ Colorado, Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Boulder, CO 80309 USA
关键词
D O I
10.1016/S0002-9149(03)00910-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In 26 patients, we evaluated a novel pulsed nasal delivery system for nitric oxide (NO) that, in the short term, was as effective as continuous delivery for decreasing pulmonary artery pressure and pulmonary vascular resistance. In 2 patients, NO delivered in the home using this pulsing system was well tolerated for up to 2 years. The long-term safety, efficacy, and acceptability of NO delivered in the home remains to be studied. (C) 2003 by Excerpta Medica, Inc.
引用
收藏
页码:886 / 890
页数:5
相关论文
共 21 条
[1]   Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing [J].
Atz, AM ;
Adatia, I ;
Lock, JE ;
Wessel, DL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (03) :813-819
[2]   Rebound pulmonary hypertension after inhalation of nitric oxide [J].
Atz, AM ;
Adatia, I ;
Wessel, DL .
ANNALS OF THORACIC SURGERY, 1996, 62 (06) :1759-1764
[3]   Inhaled nitric oxide as a preoperative test (INOP Test I) - The INOP Test Study Group [J].
Balzer, DT ;
Kort, HW ;
Day, RW ;
Corneli, HM ;
Kovalchin, JP ;
Cannon, BC ;
Kaine, SF ;
Ivy, DD ;
Webber, SA ;
Rothman, A ;
Ross, RD ;
Aggarwal, S ;
Takahashi, M ;
Waldman, JD .
CIRCULATION, 2002, 106 (13) :I76-I81
[4]   Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease [J].
Barbera, JA ;
Roger, N ;
Roca, J ;
Rovira, I ;
Higenbottam, TW ;
RodriguezRoisin, R .
LANCET, 1996, 347 (8999) :436-440
[5]   Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension [J].
Barst, RJ ;
Ivy, D ;
Dingemanse, J ;
Widlitz, A ;
Schmitt, K ;
Doran, A ;
Bingaman, D ;
Nguyen, N ;
Gaitonde, M ;
van Giersbergen, PLM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) :372-382
[6]   Vasodilator therapy for primary pulmonary hypertension in children [J].
Barst, RJ ;
Maislin, G ;
Fishman, AP .
CIRCULATION, 1999, 99 (09) :1197-1208
[7]   Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease [J].
Berner, M ;
Beghetti, M ;
SpahrSchopfer, I ;
Oberhansli, I ;
Friedli, B .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (07) :532-+
[8]   Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension - An ambulatory delivery system and initial clinical tests [J].
Channick, RN ;
Newhart, JW ;
Johnson, FW ;
Williams, PJ ;
Auger, WR ;
Fedullo, PF ;
Moser, KM .
CHEST, 1996, 109 (06) :1545-1549
[9]   PULMONARY VASODILATORY EFFECTS OF 12 AND 60 PARTS-PER-MILLION INHALED NITRIC-OXIDE IN CHILDREN WITH VENTRICULAR SEPTAL-DEFECT [J].
DAY, RW ;
LYNCH, JM ;
SHADDY, RE ;
ORSMOND, GS .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (02) :196-198
[10]  
Ivy D, 2001, Cardiol Rev, V9, P227, DOI 10.1097/00045415-200107000-00009